207 related articles for article (PubMed ID: 34092239)
1. Diagnostic yield of rare skeletal dysplasia conditions in the radiogenomics era.
Sabir AH; Morley E; Sheikh J; Calder AD; Beleza-Meireles A; Cheung MS; Cocca A; Jansson M; Lillis S; Patel Y; Yau S; Hall CM; Offiah AC; Irving M
BMC Med Genomics; 2021 Jun; 14(1):148. PubMed ID: 34092239
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and economics of targeted panel versus whole-exome sequencing in 878 patients with suspected primary immunodeficiency.
Platt CD; Zaman F; Bainter W; Stafstrom K; Almutairi A; Reigle M; Weeks S; Geha RS; Chou J;
J Allergy Clin Immunol; 2021 Feb; 147(2):723-726. PubMed ID: 32888943
[TBL] [Abstract][Full Text] [Related]
3. Whole exome and genome sequencing in mendelian disorders: a diagnostic and health economic analysis.
Ewans LJ; Minoche AE; Schofield D; Shrestha R; Puttick C; Zhu Y; Drew A; Gayevskiy V; Elakis G; Walsh C; Adès LC; Colley A; Ellaway C; Evans CA; Freckmann ML; Goodwin L; Hackett A; Kamien B; Kirk EP; Lipke M; Mowat D; Palmer E; Rajagopalan S; Ronan A; Sachdev R; Stevenson W; Turner A; Wilson M; Worgan L; Morel-Kopp MC; Field M; Buckley MF; Cowley MJ; Dinger ME; Roscioli T
Eur J Hum Genet; 2022 Oct; 30(10):1121-1131. PubMed ID: 35970915
[TBL] [Abstract][Full Text] [Related]
4. Whole genome sequencing diagnostic yield for paediatric patients with suspected genetic disorders: systematic review, meta-analysis, and GRADE assessment.
Nurchis MC; Altamura G; Riccardi MT; Radio FC; Chillemi G; Bertini ES; Garlasco J; Tartaglia M; Dallapiccola B; Damiani G
Arch Public Health; 2023 May; 81(1):93. PubMed ID: 37231492
[TBL] [Abstract][Full Text] [Related]
5. Reduced resource utilization with early use of next-generation sequencing in rare genetic diseases in an Asian cohort.
Nazeha N; Koh AL; Kam S; Lim JY; Goh DLM; Jamuar SS; Graves N
Am J Med Genet A; 2022 Dec; 188(12):3482-3491. PubMed ID: 36156406
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in neurometabolic diseases: The genetic role in the modern era.
Tein I
Epilepsy Behav; 2023 Aug; 145():109338. PubMed ID: 37453291
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Whole-Exome Sequencing for the Identification of Causal Mutations in Patients with Suspected Inherited Ocular Diseases.
Ordoñez-Labastida V; Montes-Almanza L; García-Martínez F; Zenteno JC
Rev Invest Clin; 2022; 74(4):219-226. PubMed ID: 36087940
[TBL] [Abstract][Full Text] [Related]
9. Targeted gene panel provides advantages over whole-exome sequencing for diagnosing obesity and diabetes mellitus.
Yu H; Yu H; Zhang R; Peng D; Yan D; Gu Y; Bao Y; Jia W; Zhang H; Hu C
J Mol Cell Biol; 2023 Nov; 15(6):. PubMed ID: 37327085
[TBL] [Abstract][Full Text] [Related]
10. Increase in diagnostic yield achieved for 174 whole-exome sequencing cases reanalyzed 1-2 years after initial analysis.
Liu Y; Teng Y; Li Z; Cui J; Liang D; Wu L
Clin Chim Acta; 2021 Dec; 523():163-168. PubMed ID: 34560057
[TBL] [Abstract][Full Text] [Related]
11. Clinical application of prospective whole-exome sequencing in the diagnosis of genetic disease: Experience of a regional disease center in South Korea.
Lee JY; Oh SH; Keum C; Lee BL; Chung WY
Ann Hum Genet; 2024 Mar; 88(2):101-112. PubMed ID: 37795942
[TBL] [Abstract][Full Text] [Related]
12. Re-analysis of whole-exome sequencing data uncovers novel diagnostic variants and improves molecular diagnostic yields for sudden death and idiopathic diseases.
Salfati EL; Spencer EG; Topol SE; Muse ED; Rueda M; Lucas JR; Wagner GN; Campman S; Topol EJ; Torkamani A
Genome Med; 2019 Dec; 11(1):83. PubMed ID: 31847883
[TBL] [Abstract][Full Text] [Related]
13. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients.
Tsang MHY; Chiu ATG; Kwong BMH; Liang R; Yu MHC; Yeung KS; Ho WHL; Mak CCY; Leung GKC; Pei SLC; Fung JLF; Wong VCN; Muntoni F; Chung BHY; Chan SHS
Mol Genet Genomic Med; 2020 May; 8(5):e1205. PubMed ID: 32154989
[TBL] [Abstract][Full Text] [Related]
15. Exome sequences versus sequential gene testing in the UK highly specialised Service for Limb Girdle Muscular Dystrophy.
Harris E; Topf A; Barresi R; Hudson J; Powell H; Tellez J; Hicks D; Porter A; Bertoli M; Evangelista T; Marini-Betollo C; Magnússon Ó; Lek M; MacArthur D; Bushby K; Lochmüller H; Straub V
Orphanet J Rare Dis; 2017 Sep; 12(1):151. PubMed ID: 28877744
[TBL] [Abstract][Full Text] [Related]
16. Whole-exome sequencing reanalysis at 12 months boosts diagnosis and is cost-effective when applied early in Mendelian disorders.
Ewans LJ; Schofield D; Shrestha R; Zhu Y; Gayevskiy V; Ying K; Walsh C; Lee E; Kirk EP; Colley A; Ellaway C; Turner A; Mowat D; Worgan L; Freckmann ML; Lipke M; Sachdev R; Miller D; Field M; Dinger ME; Buckley MF; Cowley MJ; Roscioli T
Genet Med; 2018 Dec; 20(12):1564-1574. PubMed ID: 29595814
[TBL] [Abstract][Full Text] [Related]
17. [Whole exome sequencing and whole genome sequencing in undiagnosed disease: of value for certain patient populations].
Linthorst GE; Hollak CEM
Ned Tijdschr Geneeskd; 2019 May; 163():. PubMed ID: 31120221
[TBL] [Abstract][Full Text] [Related]
18. Genetic Analysis Using a Next Generation Sequencing-Based Gene Panel in Patients With Skeletal Dysplasia: A Single-Center Experience.
Kim SJ; Lee SM; Choi JM; Jang JH; Kim HG; Kim JT; Cho JH; Sohn YB
Front Genet; 2021; 12():670608. PubMed ID: 34122524
[TBL] [Abstract][Full Text] [Related]
19. Rapid exome sequencing in critically ill children impacts acute and long-term management of patients and their families: A retrospective regional evaluation.
McDermott H; Sherlaw-Sturrock C; Baptista J; Hartles-Spencer L; Naik S
Eur J Med Genet; 2022 Sep; 65(9):104571. PubMed ID: 35842091
[TBL] [Abstract][Full Text] [Related]
20. The current benefit of genome sequencing compared to exome sequencing in patients with developmental or epileptic encephalopathies.
Grether A; Ivanovski I; Russo M; Begemann A; Steindl K; Abela L; Papik M; Zweier M; Oneda B; Joset P; Rauch A
Mol Genet Genomic Med; 2023 May; 11(5):e2148. PubMed ID: 36785910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
